{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:29:48Z","timestamp":1793316588173,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3735-1","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T11:11:14Z","timestamp":1510225874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation"],"prefix":"10.1186","volume":"17","author":[{"given":"Linda","family":"Bouwman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corien M.","family":"Eeltink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J. W. M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda M.","family":"Maaskant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"3735_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-6143.2008.02495.x","volume":"9","author":"RN Fine","year":"2009","unstructured":"Fine RN, Becker Y, De Geest S, Eisen H, Ettenger R, Evans R, Rudow DL, McKay D, Neu A, Nevins T, Reyes J, Wray J, Dobbels F. Non-adherence consensus conference summary report. Am J Transplant. 2009;9:35\u201341.","journal-title":"Am J Transplant"},{"key":"3735_CR2","unstructured":"World Health Organization. (2001). Innovative care for chronic conditions. Building blocks for actions. World Health Organization, www.who.int\/chp\/knowledge\/publications\/icccglobalreport.pdf?ua=1 (Assessed at July 2, 2014)."},{"issue":"12","key":"3735_CR3","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1185\/03007995.2010.533648","volume":"26","author":"EQ Wu","year":"2010","unstructured":"Wu EQ, Guerin A, Yu AP, Bollue VK, Guo A, Griffin JD. Retrospective real-world comparison of medical visits, costs and adherence between nilitinib and dasatinib in chronic myeloid leukaemia. Curr Med Res Opin. 2010;26(12):2861\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"17","key":"3735_CR4","first-page":"1890","volume":"168","author":"AJ Leendertse","year":"2008","unstructured":"Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890\u20136.","journal-title":"Arch Intern Med"},{"key":"3735_CR5","unstructured":"Sabat\u00e9, E. (2003). Adherence to long-term therapies, evidence for action. World Health Organization, apps.who.int \/medicinedocs\/pdf\/s4883e\/s4883e.pdf (Assessed at July 2, 2014)."},{"issue":"2","key":"3735_CR6","first-page":"85","volume":"66","author":"V Foulon","year":"2011","unstructured":"Foulon V, Schoffski P, Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg. 2011;66(2):85\u201396.","journal-title":"Acta Clin Belg"},{"key":"3735_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.critrevonc.2015.08.025","volume":"97","author":"AE Hall","year":"2016","unstructured":"Hall AE, Paul C, Bryant J, Lynagh MC, Rowlings P, Enjeti A, Small H. To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients. Crit Rev Oncol Hematol. 2016;97:247\u201362.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3735_CR8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ctrv.2012.12.014","volume":"39","author":"M Verbrugge","year":"2013","unstructured":"Verbrugge M, Verhaegue S, Lauwaert K, Beeckman D, Hecke van A. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: systematic review. Cancer Treat Rev. 2013;39:610\u201321.","journal-title":"Cancer Treat Rev"},{"key":"3735_CR9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdt433","volume":"25","author":"MT Puts","year":"2014","unstructured":"Puts MT, Tu HA, Tourangeau A, Howell D, Fitch M, Springall E, Alibhai SM. Factors influencing adherence to cancer treatment in older adults with cancer. A systematic review Annals of Oncology. 2014;25:564\u201377.","journal-title":"A systematic review Annals of Oncology"},{"issue":"6","key":"3735_CR10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/bjc.2012.348","volume":"107","author":"Efficace,,F., Baccarani, M., Rosti, G., Cottone, F., Castagnetti, F., Breccia, M., Alimena, G., Iurlo, A., Rossi, A. R., Pardini, S., Gherlinzoni, F., Salvucci, M., Tiribelli, M., Vignetti, M., Mandelli, F","year":"2012","unstructured":"Efficace,,F., Baccarani, M., Rosti, G., Cottone, F., Castagnetti, F., Breccia, M., Alimena, G., Iurlo, A., Rossi, A. R., Pardini, S., Gherlinzoni, F., Salvucci, M., Tiribelli, M., Vignetti, M., Mandelli, F. Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. Br J Cancer. 2012;107(6):904\u20139.","journal-title":"Br J Cancer"},{"key":"3735_CR11","unstructured":"Sabat\u00e9, E. (2001). Adherence to long-term therapies: policy for action. World Health Organization, www.who.int\/chp\/knowledge\/publications\/adherencerep.pdf (Assessed at July 2, 2014)."},{"key":"3735_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J. 2006;333:15\u201321.","journal-title":"Br Med J"},{"key":"3735_CR13","unstructured":"Marin, D., Bazeos, A., Mahon, F.X., Eliasson, L., Milojkovic, D., Bua, M., Apperley, J.F., Szydlo, R., Desai, R., Kozlowski, K., Paliompeis, C., Latham, V., Foroni, L., Molimard, M., Reid, A., Rezvani, K., Lavallade de, H., Guallar, C., Goldman, J., Khorashad, J.S. (2010). Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol, 28(14):2381\u20132388."},{"key":"3735_CR14","doi-asserted-by":"crossref","unstructured":"Weingart, S.N., Brown, E., Bach, P.B., Eng, K., Johnson, S.A., Kuzel, T.M., Langbaum, T.S., Leedy, R.D., Muller, R.J., Newcomer, L.N., O'Brien, S., Reinke, D., Rubino, M., Saltz, L., Walters, R.S. (2008). NCCN task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network, 6 (sup. 3), s.1\u201314.","DOI":"10.6004\/jnccn.2008.2003"},{"key":"3735_CR15","doi-asserted-by":"crossref","unstructured":"Aisner, J. (2007). Overview of the changing paradigm in cancer treatment: oral chemotherapy. American Journal of Health-System Pharmacy, 64 (9) (sup 5) s. 4\u20137.","DOI":"10.2146\/ajhp070035"},{"key":"3735_CR16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.leukres.2012.01.021","volume":"36","author":"A Gater","year":"2012","unstructured":"Gater A, Heron L, Abetz-Webb L, Coombs J, Simmons J, Guilhot F, Rea D. Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia. Leuk Res. 2012;36:817\u201325.","journal-title":"Leuk Res"},{"key":"3735_CR17","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","volume":"113","author":"L Noens","year":"2009","unstructured":"Noens L, van Lierde M, De Bock R, Verhoef G, Zach\u00e9e P, Berneman Z, Martiat P, Mineur P, van Eygen K, MacDonald K, de Geest S, Albrecht T, Abraham I. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113:5401\u201311.","journal-title":"Blood"},{"issue":"1\u20133","key":"3735_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2007.10.029","volume":"100","author":"L Fialko","year":"2008","unstructured":"Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D. A large-scale validation study of the medication adherence rating scale (MARS). Schizophr Res. 2008;100(1\u20133):53\u20139.","journal-title":"Schizophr Res"},{"key":"3735_CR19","doi-asserted-by":"crossref","unstructured":"Thompson, K., Kulkarni, J., Sergejew, A.A. (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research. 5; 42(3):241\u2013247.","DOI":"10.1016\/S0920-9964(99)00130-9"},{"issue":"1","key":"3735_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1\u201324.","journal-title":"Psychol Health"},{"issue":"6","key":"3735_CR21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","volume":"46","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J. Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;46(6):555\u201367.","journal-title":"J Psychosom Res"},{"issue":"6","key":"3735_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"3735_CR23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjellan","year":"2002","unstructured":"Bjellan I, Dahl AA, Haug T. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69\u201377.","journal-title":"J Psychosom Res"},{"key":"3735_CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0033291796004382","volume":"27","author":"P Spinhoven","year":"1997","unstructured":"Spinhoven P, Ormel J, Sloekers PPA, Kempen GJM, Speckens AEM, Van Hemert AM. A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27:363\u201370.","journal-title":"Psychol Med"},{"key":"3735_CR25","unstructured":"Evers, A.W.M., Kraaimaat, F.W., van Lankveld, W., Bijlsma, J.W.J. (1998). De Ziekte Cognitie Lijst (ZCL) (The Illness Cognition Questionnaire: ICQ). Gedragstherapie, 31:205\u2013220."},{"issue":"6","key":"3735_CR26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1037\/0022-006X.69.6.1026","volume":"69","author":"AWM Evers","year":"2001","unstructured":"Evers AWM, Kraaimaat FW, van Lankveld W, Jongen PHJ, Jacobs WWG, Bijlsma JWJ. Beyond unfavorable thinking: illness cognition questionnaire for chronic diseases. J Consult Clin Psychol. 2001;69(6):1026\u201336.","journal-title":"J Consult Clin Psychol"},{"key":"3735_CR27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12529-009-9059-z","volume":"17","author":"E Lauwerier","year":"2009","unstructured":"Lauwerier E, Crombez G, Van Damme S, Goubert L, Vogelaers D, Evers AWM. The construct validity of the illness cognition questionnaire: the robustness of the three-factor structure across patients with chronic pain and chronic fatigue. International Journal of Behavioral Medicine. 2009;17:90\u20136.","journal-title":"International Journal of Behavioral Medicine"},{"key":"3735_CR28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F. The European organisation for research andbTreatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"3735_CR29","unstructured":"Fayers, P., Aaronson, N.K., Bjordal, K., Curran, D., Groenvold, M. (2001). The EORTC QLQ-C30 Scoring Manual (3rd edition). European Organisation for Research and Treatment of Cancer, www.eortc.be\/qol\/files\/SCManualQLQ-C30.pdf (Assessed at July 2, 2014)."},{"key":"3735_CR30","unstructured":"Bouwman L, Eeltink CM, Visser O, Maaskant JM. Medication non-adherence in hematological-oncological patients in their home situation, the nurses group poster session. EBMT. 2015;2015 https:\/\/www.nature.com\/bmt\/journal\/v50\/n1s\/pdf\/bmt201532a.pdf"},{"key":"3735_CR31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-199812270-00026","volume":"66","author":"S Greenstein","year":"1998","unstructured":"Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation. 1998;66:1718.","journal-title":"Transplantation"},{"key":"3735_CR32","unstructured":"De Vera, M.A., Marcotte, G., Rai, S., Galo, J.S., Bhole, V. (2014). Medication Adherence in Gout: A Systematic Review. Arthritis Care & Research, (Epub, ahead of print)."},{"key":"3735_CR33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood-2009-07-229948","volume":"114","author":"M StCharles","year":"2009","unstructured":"StCharles M, Bollu VK, Hornyak E, Coombs J, Blanchette CM, DeAngelo DJ. Predictors of treatment non-adherence in patients treated with Imatinib Mesylate for chronic myeloid leukemia. Blood. 2009;114:2209.","journal-title":"Blood"},{"key":"3735_CR34","doi-asserted-by":"crossref","unstructured":"Larizza MA, Dooley MJ, Kay SK, Kong DCM. Factors influencing adherence to molecular therapies in Haematology-oncology outpatients. Pharmacy practice and research. 2006;36(2)","DOI":"10.1002\/j.2055-2335.2006.tb00584.x"},{"key":"3735_CR35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00432-017-2372-z","volume":"143","author":"J Geissler","year":"2017","unstructured":"Geissler J, Sharf G, Bombaci F, Daban M, De Jong J, Gavin T, Pelouchova J, Dziwinski E, Hasford J, Hoffmann VS. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries. Journal of Cancer Research and Clinical Oncology. 2017;143:1167\u201376.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"3735_CR36","doi-asserted-by":"crossref","unstructured":"Dobbels F, Vanhaecke J, Dupont L, Nevens F, Verleden G, Pirenne J, Geest de S. Pretansplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 27; 87(10). 2009:1497\u2013504.","DOI":"10.1097\/TP.0b013e3181a440ae"},{"issue":"1","key":"3735_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17474086.2017.1262758","volume":"10","author":"F De Marchi","year":"2017","unstructured":"De Marchi F, Medeot M, Fanin R, Tiribelli M. How could patient reported outcomes improve patient management in chronic myeloid leukemia? Expert Rev Hematol. 2017;10(1):9\u201314.","journal-title":"Expert Rev Hematol"},{"key":"3735_CR38","unstructured":"Timmers, L., Boons, C.C.L.M., Mangnus, D., Van de Ven, P.M., Van den Berg, P.H., Beeker, A., Swart, E.L., Honeywell, R.J., Peters, G. J., Boven, E., Hugtenburg, J.G. (2016). Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice. Frontiers in Pharmacol., Sep 21;7:310."},{"issue":"2","key":"3735_CR39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/0284186X.2013.844353","volume":"53","author":"L Timmers","year":"2013","unstructured":"Timmers L, Boons CCLM, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JNH, Boven E, Hugtenburg JG. Adherence and patients\u2019 experiences with the use of oral anticancer agents. Acta Oncology. 2013;53(2):259\u201367.","journal-title":"Acta Oncology"},{"issue":"5","key":"3735_CR40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00277-011-1359-0","volume":"91","author":"S J\u00f6nsson","year":"2012","unstructured":"J\u00f6nsson S, Olsson B, S\u00f6derberg J, Wadenvik H. Good adherence to imatinib therapy among patients with chronic myeloid leukemia\u2014a single-center observational study. Ann Hematol. 2012;91(5):679\u201385.","journal-title":"Ann Hematol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3735-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T12:42:32Z","timestamp":1603284152000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3735-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3735"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3735-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"article-number":"739"}}